Sirtuin 1 Regulates SREBP-1c Expression in a LXR-Dependent Manner in Skeletal Muscle

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Defour, Aurélia ^a   Dessalle, Kevin ^a   Castro Perez, Andréa ^a   Poyot, Thomas ^b   Castells, Josiane ^a   Gallot, Yann Simon ^a   Durand, Christine ^a   Euthine, Vanessa ^a   Gu, Yansong ^c   Béchet, Daniel ^d   Peinnequin, André ^b   Lefai, Etienne ^a   Freyssenet, Damien ^a  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE DE RECHERCHES   (France)

^c Obenomics Inc   (United States)

^d INRA and University of Auvergne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MESSENGER RNA; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; ELECTROPORATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HISTONE ACETYLATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIPOGENESIS; MALE; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN FUNCTION; SKELETAL MUSCLE;

ACETYLATION; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MUSCLE CELLS; MUSCLE, SKELETAL; ORPHAN NUCLEAR RECEPTORS; PROMOTER REGIONS, GENETIC; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTIONAL ACTIVATION;

MAMMALIA; MUS;

EID: 84866289380     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043490     Document Type: Article

References (46)

1. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I, (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16: 4623-4635.
2. Michan S, Sinclair D, (2007) Sirtuins in mammals: insights into their biological function. Biochem J 404: 1-13.
3. Brooks CL, Gu W, (2009) How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 9: 123-128.
4. Yu J, Auwerx J, (2010) Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation. Pharmacol Res 62: 35-41.
5. Yu J, Auwerx J, (2009) The role of sirtuins in the control of metabolic homeostasis. Ann N Y Acad Sci 1173 Suppl 1: E10-19.
6. Canto C, Auwerx J, (2012) Targeting sirtuin 1 to improve metabolism: all you need is NAD+? Pharmacol Rev 64: 166-187.
7. Luo J, Nikolaev AY, Imai S, Chen D, Su F, et al. (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148.
8. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, et al. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
9. Lerin C, Rodgers JT, Kalume DE, Kim SH, Pandey A, et al. (2006) GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab 3: 429-438.
10. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, et al. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113-118.
11. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015.
12. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, et al. (2004) Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-563.
13. Li X, Zhang S, Blander G, Tse JG, Krieger M, et al. (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 28: 91-106.
14. Walker AK, Yang F, Jiang K, Ji JY, Watts JL, et al. (2010) Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev 24: 1403-1417.
15. Rodgers JT, Puigserver P, (2007) Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci U S A 104: 12861-12866.
16. Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, et al. (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 285: 33959-33970.
17. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F, (2004) SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86: 839-848.
18. Dif N, Euthine V, Gonnet E, Laville M, Vidal H, et al. (2006) Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem J 400: 179-188.
19. Guillet-Deniau I, Mieulet V, Le Lay S, Achouri Y, Carre D, et al. (2002) Sterol regulatory element binding protein-1c expression and action in rat muscles: insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression. Diabetes 51: 1722-1728.
20. Rome S, Lecomte V, Meugnier E, Rieusset J, Debard C, et al. (2008) Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle. Physiol Genomics 34: 327-337.
21. Giandomenico V, Simonsson M, Gronroos E, Ericsson J, (2003) Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol Cell Biol 23: 2587-2599.
22. Calkin AC, Tontonoz P, (2012) Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 13: 213-224.
23. Yoshikawa T, Shimano H, Amemiya-Kudo M, Yahagi N, Hasty AH, et al. (2001) Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol 21: 2991-3000.
24. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, et al. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 14: 2819-2830.
25. Cozzone D, Debard C, Dif N, Ricard N, Disse E, et al. (2006) Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells. Diabetologia 49: 990-999.
26. Lecomte V, Meugnier E, Euthine V, Durand C, Freyssenet D, et al. (2010) A new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation. Mol Cell Biol 30: 1182-1198.
27. Qiang L, Lin HV, Kim-Muller JY, Welch CL, Gu W, et al. (2011) Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metab 14: 758-767.
28. Muscat GE, Wagner BL, Hou J, Tangirala RK, Bischoff ED, et al. (2002) Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors. J Biol Chem 277: 40722-40728.
29. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, et al. (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14: 612-622.
30. Um JH, Park SJ, Kang H, Yang S, Foretz M, et al. (2010) AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59: 554-563.
31. Canto C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, et al. (2010) Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle. Cell Metab 11: 213-219.
32. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, et al. (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458: 1056-1060.
33. Erion DM, Yonemitsu S, Nie Y, Nagai Y, Gillum MP, et al. (2009) SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proc Natl Acad Sci U S A 106: 11288-11293.
34. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, et al. (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 9: 327-338.
35. Gosmain Y, Dif N, Berbe V, Loizon E, Rieusset J, et al. (2005) Regulation of SREBP-1 expression and transcriptional action on HKII and FAS genes during fasting and refeeding in rat tissues. J Lipid Res 46: 697-705.
36. Gosmain Y, Lefai E, Ryser S, Roques M, Vidal H, (2004) Sterol regulatory element-binding protein-1 mediates the effect of insulin on hexokinase II gene expression in human muscle cells. Diabetes 53: 321-329.
37. Ducluzeau PH, Perretti N, Laville M, Andreelli F, Vega N, et al. (2001) Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes 50: 1134-1142.
38. Frojdo S, Durand C, Molin L, Carey AL, El-Osta A, et al. (2011) Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 335: 166-176.
39. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, et al. (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A 100: 10794-10799.
40. Abdelmohsen K, Pullmann R, Lal A, Kim HH, Galban S, et al. (2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25: 543-557.
41. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
42. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
43. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J, (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
44. Durieux AC, Bonnefoy R, Freyssenet D, (2005) Kinetic of transgene expression after electrotransfer into skeletal muscle: Importance of promoter origin/strength. Biochim Biophys Acta 1725: 403-409.
45. Durieux AC, Bonnefoy R, Manissolle C, Freyssenet D, (2002) High-efficiency gene electrotransfer into skeletal muscle: description and physiological applicability of a new pulse generator. Biochem Biophys Res Commun 296: 443-450.
46. Durieux AC, Bonnefoy R, Busso T, Freyssenet D, (2004) In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage. J Gene Med 6: 809-816.